• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tocilizumab in the treatment of severe and/or refractory vasculo-Behçet's disease: a single-centre experience in China.

作者信息

Ding Yanxia, Li Chaoran, Liu Jinjing, Yu Xin, Wang Yining, Shi Jing, Li Lu, Zhou Jiaxin, Wang Li, Chen Hua, Zhao Yan, Zheng Wenjie

机构信息

Department of Rheumatology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences, Peking Union Medical College, The Ministry of Education Key Laboratory, Beijing, China.

Department of Rheumatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Rheumatology (Oxford). 2018 Nov 1;57(11):2057-2059. doi: 10.1093/rheumatology/key230.

DOI:10.1093/rheumatology/key230
PMID:30107599
Abstract
摘要

相似文献

1
Tocilizumab in the treatment of severe and/or refractory vasculo-Behçet's disease: a single-centre experience in China.托珠单抗治疗重度和/或难治性血管性白塞病：中国单中心经验
Rheumatology (Oxford). 2018 Nov 1;57(11):2057-2059. doi: 10.1093/rheumatology/key230.
2
Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.一名白塞病难治性葡萄膜炎患者从英夫利昔单抗转换为阿达木单抗的疗效。
Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S93. Epub 2011 Sep 27.
3
Effectiveness of tocilizumab in Behcet's disease: A systematic literature review.托珠单抗治疗白塞病的有效性：系统文献回顾。
Semin Arthritis Rheum. 2020 Aug;50(4):797-804. doi: 10.1016/j.semarthrit.2020.05.017. Epub 2020 Jun 5.
4
A case of refractory intestinal Behçet's disease treated with tocilizumab, a humanised anti-interleukin-6 receptor antibody.1例难治性肠道白塞病采用人源化抗白细胞介素-6受体抗体托珠单抗治疗。
Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):116-118. Epub 2017 Sep 21.
5
A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.一例采用人源化抗白细胞介素-6 受体抗体托珠单抗治疗的贝赫切特病。
Mod Rheumatol. 2012 Apr;22(2):298-302. doi: 10.1007/s10165-011-0497-5. Epub 2011 Jul 12.
6
Tocilizumab treatment for neuro-Behcet's disease, the first report.托珠单抗治疗神经白塞病的首例报告
Clin Neurol Neurosurg. 2012 Apr;114(3):297-8. doi: 10.1016/j.clineuro.2011.10.024. Epub 2011 Nov 9.
7
Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.阿达木单抗治疗重度白塞氏葡萄膜炎：一项回顾性长期随访研究。
Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S58-62. Epub 2014 Jul 8.
8
Tocilizumab in severe and refractory Behcet's disease: Four cases and literature review.托珠单抗治疗重症和难治性白塞病：4 例病例并文献复习。
Semin Arthritis Rheum. 2016 Jun;45(6):733-7. doi: 10.1016/j.semarthrit.2015.11.012. Epub 2015 Dec 2.
9
Efficacy and safety of tocilizumab in neuro-Behçet's disease: A case report.托珠单抗治疗神经白塞病的疗效与安全性：一例报告
Rev Neurol (Paris). 2017 Mar;173(3):171-172. doi: 10.1016/j.neurol.2017.02.006. Epub 2017 Mar 22.
10
[Treatment of Behçet's disease with adalimumab].[阿达木单抗治疗白塞病]
Med Clin (Barc). 2008 Oct 4;131(11):438-9. doi: 10.1157/13126223.

引用本文的文献

1
Arterial and venous thrombosis in systemic and monogenic vasculitis.系统性和单基因血管炎中的动脉和静脉血栓形成
Nat Rev Rheumatol. 2025 May 6. doi: 10.1038/s41584-025-01252-7.
2
New and future perspectives in Behçet's syndrome.白塞病的新观点与未来展望。
Arch Rheumatol. 2024 Dec 18;39(4):511-521. doi: 10.46497/ArchRheumatol.2024.11049. eCollection 2024 Dec.
3
Treatment Options in Pediatric Behçet's Disease.儿童贝赫切特病的治疗选择。
Paediatr Drugs. 2023 Mar;25(2):165-191. doi: 10.1007/s40272-022-00548-5. Epub 2023 Jan 10.
4
The Th17 Pathway in Vascular Inflammation: Culprit or Consort?Th17 通路在血管炎症中的作用：始作俑者还是同谋？
Front Immunol. 2022 Apr 11;13:888763. doi: 10.3389/fimmu.2022.888763. eCollection 2022.
5
Efficacy and safety of tocilizumab in Behçet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China.托珠单抗治疗贝赫切特综合征伴难治性动脉病变的疗效和安全性：中国单中心观察性队列研究。
Rheumatology (Oxford). 2022 Jul 6;61(7):2923-2930. doi: 10.1093/rheumatology/keab840.
6
Perioperative management with biologics on severe aortic valve regurgitation caused by Behçet syndrome: the experience from a single center.白塞病所致重度主动脉瓣反流的围手术期生物制剂治疗管理：单中心经验
Ther Adv Chronic Dis. 2021 Jun 22;12:20406223211026753. doi: 10.1177/20406223211026753. eCollection 2021.
7
Advances in the Treatment of Behcet's Disease.贝赫切特病治疗进展。
Curr Rheumatol Rep. 2021 May 20;23(6):47. doi: 10.1007/s11926-021-01011-z.
8
Biologic treatments in Behçet's disease.白塞病的生物治疗
Eur J Rheumatol. 2021 Oct;8(4):217-222. doi: 10.5152/eurjrheum.2020.20138.
9
Experimental Therapeutic Solutions for Behcet's Disease.白塞病的实验性治疗方案
J Exp Pharmacol. 2021 Feb 12;13:127-145. doi: 10.2147/JEP.S265645. eCollection 2021.
10
[Progress in interferon: A treatment of Behcet syndrome].[干扰素的进展：白塞综合征的一种治疗方法]
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Dec 18;52(6):1166-1170. doi: 10.19723/j.issn.1671-167X.2020.06.032.